The advanced wound care market size has grown strongly in recent years. It will grow from $11.61 billion in 2025 to $12.43 billion in 2026 at a compound annual growth rate (CAGR) of 7%. The growth in the historic period can be attributed to rising prevalence of chronic and acute wounds, expansion of hospital wound care departments, increasing incidence of surgical wounds, growing diabetic population, availability of advanced wound care products.
The advanced wound care market size is expected to see strong growth in the next few years. It will grow to $16.43 billion in 2030 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to increasing demand for advanced wound healing solutions, rising adoption of home healthcare wound management, expansion of personalized wound treatment approaches, growing focus on reducing healing time, increasing investment in wound care innovation. Major trends in the forecast period include increasing adoption of moist wound healing technologies, rising use of antimicrobial and active dressings, growing integration of npwt systems, expansion of bioengineered skin substitutes, enhanced focus on chronic wound management.
The increasing prevalence of diabetes is anticipated to accelerate the growth of the advanced wound care devices market in the coming years. Diabetes is a long-term medical condition marked by persistently high blood glucose levels caused by the body’s inability to produce sufficient insulin or effectively utilize it, with insulin playing a key role in blood sugar regulation. The rising incidence of diabetes is generating greater demand for specialized advanced wound care devices, underscoring the need for ongoing innovation and sustained investment to address the specific complexities of diabetic wounds and improve patient outcomes. Advanced wound care supports diabetic patients by facilitating faster healing of chronic wounds, lowering infection risk, preventing severe complications such as ulcers or amputations, and enhancing overall skin integrity. For example, in June 2024, according to the National Health Service, a United Kingdom-based government department, in 2023 the National Health Service identified more than half a million additional individuals in England at risk of developing type 2 diabetes, increasing the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a general practitioner to 3,615,330. This marked a substantial rise from 3,065,825 in 2022, reflecting an increase of nearly 20%. Therefore, the growing burden of diabetes is contributing to the expansion of the advanced wound care devices market.
Major companies operating in the advanced wound care sector are increasingly focused on developing innovative solutions, including portable and patient-friendly negative pressure wound therapy (NPWT) systems, to address the growing demand for accessible, home-based chronic wound management as healthcare delivery continues to shift toward outpatient care and remote monitoring. Negative pressure wound therapy works by applying controlled sub-atmospheric pressure to wounds, which promotes healing through the removal of excess fluid, reduction of edema, and stimulation of tissue regeneration; unlike conventional dressings, NPWT offers active and continuous wound management rather than passive protection. For instance, in April 2024, Smith+Nephew PLC, a United Kingdom-based medical technology company, launched the RENASYS EDGE NPWT System in the United States, a compact, lightweight, and low-noise device designed for home use by patients with chronic wounds. The system features a discreet canister and a near-field communication interface that provides step-by-step setup guidance, supports continuous therapy in ambulatory settings, operates quietly to maintain discretion, and is supported by 24-hour clinical assistance. In addition, Smith+Nephew partnered with national distributors, including SunMED Medical Solutions and First Nation Group, to broaden product availability, thereby supporting greater patient independence and treatment adherence.
In July 2023, Coloplast A/S, a Denmark-based healthcare technology company, completed the acquisition of Kerecis Limited for up to USD 1.3 billion. Through this acquisition, Coloplast A/S sought to strengthen its strategic position in the advanced wound care space by expanding into the fast-growing, United States-focused biologics segment. Kerecis Limited is an Iceland-based biotechnology company specializing in intact fish-skin-derived soft tissue regeneration products for wound healing, utilizing a patented platform that preserves the natural skin structure to support the repair of chronic, surgical, and burn wounds.
Major companies operating in the advanced wound care market are Integra LifeSciences Corp., Mölnlycke Health Care, Johnson & Johnson Services Inc., Medline Industries Inc., Medtronic plc, Organogenesis Holdings Inc., Smith & Nephew plc, B. Braun Melsungen AG, Coloplast A/S, ConvaTec Group plc, Hollister Incorporated, URGO Medical Ltd., Lohmann & Rauscher GmbH & Co. KG, MiMedx Group Inc., BSN medical GmbH, Paul Hartmann AG, Johnson & Johnson Medical Devices Group, Beiersdorf AG, Zimmer Biomet Holdings Inc., Misonix Inc., Cardinal Health Inc., Nestlé Health Science SA, Becton Dickinson and Company.
North America was the largest region in the advanced wound care devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the advanced wound care devices market report during the forecast period. The regions covered in the advanced wound care market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the advanced wound care market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the advanced wound care market by increasing costs of imported bioengineered materials, NPWT components, antimicrobial agents, and specialized wound care devices. Hospitals and specialty clinics in North America and Europe are most affected due to reliance on imported high-value wound care technologies, while Asia-Pacific faces pricing pressure on advanced treatment products. These tariffs are increasing treatment costs and influencing procurement decisions. However, they are also driving local production, regional supplier partnerships, and innovation in cost-efficient advanced wound care solutions.
The advanced wound care market research report is one of a series of new reports that provides advanced wound care market statistics, including advanced wound care industry global market size, regional shares, competitors with a advanced wound care market share, detailed advanced wound care market segments, market trends and opportunities, and any further data you may need to thrive in the advanced wound care industry. This advanced wound care market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Advanced wound care involves the treatment of chronic or complex wounds using specialized products that are not readily available over the counter. This approach offers various advantages, including the regulation of body temperature, prevention of infections, removal of dead tissue, avoidance of scar formation, and alleviation of discomfort during dressing changes. It is particularly beneficial for healing complex or difficult-to-treat wounds.
The primary types of advanced wound care devices include moist, antimicrobial, and active variants. Antimicrobial devices incorporate agents designed to eliminate or prevent the growth of microorganisms such as bacteria, spores, or protozoa, specifically targeting bacterial presence in wounds. These devices find applications in treating both chronic and acute wounds and are utilized by various end-users, including hospitals, specialty clinics, home healthcare settings, and others.
The advanced wound care market consists of sales of advanced wound dressings, and infection prevention dressings. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The advanced wound care market size is expected to see strong growth in the next few years. It will grow to $16.43 billion in 2030 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to increasing demand for advanced wound healing solutions, rising adoption of home healthcare wound management, expansion of personalized wound treatment approaches, growing focus on reducing healing time, increasing investment in wound care innovation. Major trends in the forecast period include increasing adoption of moist wound healing technologies, rising use of antimicrobial and active dressings, growing integration of npwt systems, expansion of bioengineered skin substitutes, enhanced focus on chronic wound management.
The increasing prevalence of diabetes is anticipated to accelerate the growth of the advanced wound care devices market in the coming years. Diabetes is a long-term medical condition marked by persistently high blood glucose levels caused by the body’s inability to produce sufficient insulin or effectively utilize it, with insulin playing a key role in blood sugar regulation. The rising incidence of diabetes is generating greater demand for specialized advanced wound care devices, underscoring the need for ongoing innovation and sustained investment to address the specific complexities of diabetic wounds and improve patient outcomes. Advanced wound care supports diabetic patients by facilitating faster healing of chronic wounds, lowering infection risk, preventing severe complications such as ulcers or amputations, and enhancing overall skin integrity. For example, in June 2024, according to the National Health Service, a United Kingdom-based government department, in 2023 the National Health Service identified more than half a million additional individuals in England at risk of developing type 2 diabetes, increasing the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a general practitioner to 3,615,330. This marked a substantial rise from 3,065,825 in 2022, reflecting an increase of nearly 20%. Therefore, the growing burden of diabetes is contributing to the expansion of the advanced wound care devices market.
Major companies operating in the advanced wound care sector are increasingly focused on developing innovative solutions, including portable and patient-friendly negative pressure wound therapy (NPWT) systems, to address the growing demand for accessible, home-based chronic wound management as healthcare delivery continues to shift toward outpatient care and remote monitoring. Negative pressure wound therapy works by applying controlled sub-atmospheric pressure to wounds, which promotes healing through the removal of excess fluid, reduction of edema, and stimulation of tissue regeneration; unlike conventional dressings, NPWT offers active and continuous wound management rather than passive protection. For instance, in April 2024, Smith+Nephew PLC, a United Kingdom-based medical technology company, launched the RENASYS EDGE NPWT System in the United States, a compact, lightweight, and low-noise device designed for home use by patients with chronic wounds. The system features a discreet canister and a near-field communication interface that provides step-by-step setup guidance, supports continuous therapy in ambulatory settings, operates quietly to maintain discretion, and is supported by 24-hour clinical assistance. In addition, Smith+Nephew partnered with national distributors, including SunMED Medical Solutions and First Nation Group, to broaden product availability, thereby supporting greater patient independence and treatment adherence.
In July 2023, Coloplast A/S, a Denmark-based healthcare technology company, completed the acquisition of Kerecis Limited for up to USD 1.3 billion. Through this acquisition, Coloplast A/S sought to strengthen its strategic position in the advanced wound care space by expanding into the fast-growing, United States-focused biologics segment. Kerecis Limited is an Iceland-based biotechnology company specializing in intact fish-skin-derived soft tissue regeneration products for wound healing, utilizing a patented platform that preserves the natural skin structure to support the repair of chronic, surgical, and burn wounds.
Major companies operating in the advanced wound care market are Integra LifeSciences Corp., Mölnlycke Health Care, Johnson & Johnson Services Inc., Medline Industries Inc., Medtronic plc, Organogenesis Holdings Inc., Smith & Nephew plc, B. Braun Melsungen AG, Coloplast A/S, ConvaTec Group plc, Hollister Incorporated, URGO Medical Ltd., Lohmann & Rauscher GmbH & Co. KG, MiMedx Group Inc., BSN medical GmbH, Paul Hartmann AG, Johnson & Johnson Medical Devices Group, Beiersdorf AG, Zimmer Biomet Holdings Inc., Misonix Inc., Cardinal Health Inc., Nestlé Health Science SA, Becton Dickinson and Company.
North America was the largest region in the advanced wound care devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the advanced wound care devices market report during the forecast period. The regions covered in the advanced wound care market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the advanced wound care market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the advanced wound care market by increasing costs of imported bioengineered materials, NPWT components, antimicrobial agents, and specialized wound care devices. Hospitals and specialty clinics in North America and Europe are most affected due to reliance on imported high-value wound care technologies, while Asia-Pacific faces pricing pressure on advanced treatment products. These tariffs are increasing treatment costs and influencing procurement decisions. However, they are also driving local production, regional supplier partnerships, and innovation in cost-efficient advanced wound care solutions.
The advanced wound care market research report is one of a series of new reports that provides advanced wound care market statistics, including advanced wound care industry global market size, regional shares, competitors with a advanced wound care market share, detailed advanced wound care market segments, market trends and opportunities, and any further data you may need to thrive in the advanced wound care industry. This advanced wound care market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Advanced wound care involves the treatment of chronic or complex wounds using specialized products that are not readily available over the counter. This approach offers various advantages, including the regulation of body temperature, prevention of infections, removal of dead tissue, avoidance of scar formation, and alleviation of discomfort during dressing changes. It is particularly beneficial for healing complex or difficult-to-treat wounds.
The primary types of advanced wound care devices include moist, antimicrobial, and active variants. Antimicrobial devices incorporate agents designed to eliminate or prevent the growth of microorganisms such as bacteria, spores, or protozoa, specifically targeting bacterial presence in wounds. These devices find applications in treating both chronic and acute wounds and are utilized by various end-users, including hospitals, specialty clinics, home healthcare settings, and others.
The advanced wound care market consists of sales of advanced wound dressings, and infection prevention dressings. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Advanced Wound Care Market Characteristics
3. Advanced Wound Care Market Supply Chain Analysis
4. Global Advanced Wound Care Market Trends and Strategies
5. Advanced Wound Care Market Analysis of End Use Industries
7. Global Advanced Wound Care Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Advanced Wound Care Total Addressable Market (TAM) Analysis for the Market
9. Advanced Wound Care Market Segmentation
10. Advanced Wound Care Market Regional and Country Analysis
11. Asia-Pacific Advanced Wound Care Market
12. China Advanced Wound Care Market
13. India Advanced Wound Care Market
14. Japan Advanced Wound Care Market
15. Australia Advanced Wound Care Market
16. Indonesia Advanced Wound Care Market
17. South Korea Advanced Wound Care Market
18. Taiwan Advanced Wound Care Market
19. South East Asia Advanced Wound Care Market
20. Western Europe Advanced Wound Care Market
21. UK Advanced Wound Care Market
22. Germany Advanced Wound Care Market
23. France Advanced Wound Care Market
24. Italy Advanced Wound Care Market
25. Spain Advanced Wound Care Market
26. Eastern Europe Advanced Wound Care Market
27. Russia Advanced Wound Care Market
28. North America Advanced Wound Care Market
29. USA Advanced Wound Care Market
30. Canada Advanced Wound Care Market
31. South America Advanced Wound Care Market
32. Brazil Advanced Wound Care Market
33. Middle East Advanced Wound Care Market
34. Africa Advanced Wound Care Market
36. Advanced Wound Care Market Competitive Landscape and Company Profiles
37. Advanced Wound Care Market Other Major and Innovative Companies
40. Advanced Wound Care Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Advanced Wound Care Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses advanced wound care market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for advanced wound care? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The advanced wound care market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Moist; Antimicrobial; Active2) By Application: Chronic Wounds; Acute Wounds
3) By End User: Hospitals; Specialty Clinics; Home Healthcare; Other End Users
Subsegments:
1) By Moist: Hydrocolloid Dressings; Hydrogels; Foam Dressings2) By Antimicrobial: Silver-Infused Dressings; Honey-Infused Dressings; Iodine-Containing Dressings
3) By Active: Negative Pressure Wound Therapy (NPWT); Bioengineered Skin Substitutes
Companies Mentioned: Integra LifeSciences Corp.; Mölnlycke Health Care; Johnson & Johnson Services Inc.; Medline Industries Inc.; Medtronic plc; Organogenesis Holdings Inc.; Smith & Nephew plc; B. Braun Melsungen AG; Coloplast A/S; ConvaTec Group plc; Hollister Incorporated; URGO Medical Ltd.; Lohmann & Rauscher GmbH & Co. KG; MiMedx Group Inc.; BSN medical GmbH; Paul Hartmann AG; Johnson & Johnson Medical Devices Group; Beiersdorf AG; Zimmer Biomet Holdings Inc.; Misonix Inc.; Cardinal Health Inc.; Nestlé Health Science SA; Becton Dickinson and Company
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Advanced Wound Care market report include:- Integra LifeSciences Corp.
- Mölnlycke Health Care
- Johnson & Johnson Services Inc.
- Medline Industries Inc.
- Medtronic plc
- Organogenesis Holdings Inc.
- Smith & Nephew plc
- B. Braun Melsungen AG
- Coloplast A/S
- ConvaTec Group plc
- Hollister Incorporated
- URGO Medical Ltd.
- Lohmann & Rauscher GmbH & Co. KG
- MiMedx Group Inc.
- BSN medical GmbH
- Paul Hartmann AG
- Johnson & Johnson Medical Devices Group
- Beiersdorf AG
- Zimmer Biomet Holdings Inc.
- Misonix Inc.
- Cardinal Health Inc.
- Nestlé Health Science SA
- Becton Dickinson and Company
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 12.43 Billion |
| Forecasted Market Value ( USD | $ 16.43 Billion |
| Compound Annual Growth Rate | 7.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 24 |
